These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19644603)

  • 41. [Simple method for controlling anticoagulation with vitamin K antagonists during heparin therapy: rapid determination after heparin absorption by ECTEOLA cellulose].
    Schuler J; von Felten A
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1798-800. PubMed ID: 7178878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary vitamin K intake and anticoagulation in elderly patients.
    Rohde LE; de Assis MC; Rabelo ER
    Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):1-5. PubMed ID: 17143047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Which anticoagulants?].
    Wautrecht JC
    Rev Med Brux; 2002 Sep; 23(4):A375-8. PubMed ID: 12422463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Body Weight on Dose of Vitamin K Antagonists.
    Self TH; Wallace JL; Sakaan S; Sands CW
    South Med J; 2015 Oct; 108(10):637-43. PubMed ID: 26437201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
    Schellong SM; Riess H; Spannagl M; Omran H; Schwarzbach M; Langer F; Gogarten W; Bramlage P; Bauersachs RM
    Anaesthesist; 2018 Aug; 67(8):599-606. PubMed ID: 29926118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly.
    Siguret V; Gouin-Thibault I; Gaussem P; Pautas E
    Drugs Aging; 2013 Sep; 30(9):687-99. PubMed ID: 23884865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Practical aspects of the oral new anticoagulants.
    DeLoughery TG
    Am J Hematol; 2011 Jul; 86(7):586-90. PubMed ID: 21674571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?
    Tufano A; Coppola A; Contaldi P; Franchini M; Minno GD
    Semin Thromb Hemost; 2015 Jun; 41(4):382-8. PubMed ID: 25703521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The History of Antithrombotic Therapy: The Discovery of Heparin, the Vitamin K Antagonists, and the Utility of Aspirin.
    Handin RI
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):987-93. PubMed ID: 27637302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [News in angiology and hemostasis].
    Boehlen F; Blondon M; Fontana P
    Rev Med Suisse; 2016 Jan; 12(500):13-6. PubMed ID: 26946695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anticoagulants and pregnancy].
    Makatsariia AD; Limonova SG
    Akush Ginekol (Mosk); 1981 May; (5):5-8. PubMed ID: 7027813
    [No Abstract]   [Full Text] [Related]  

  • 53. Are direct oral anticoagulants such as edoxaban safer than heparin or vitamin K-antagonists when intracranial hemorrhage occurs?
    Dempfle CE
    Thromb Res; 2014 Apr; 133(4):521-2. PubMed ID: 24568776
    [No Abstract]   [Full Text] [Related]  

  • 54. [Vitamin K antagonists overdose].
    Groszek B; Piszczek P
    Przegl Lek; 2015; 72(9):468-71. PubMed ID: 26827569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Old and new anticoagulants. Antidotes and measures for acute hemorrhaging and urgent interventions].
    Lancé M; Stessel B; Hamulyák K; Marcus MA
    Anaesthesist; 2010 Jan; 59(1):62, 64-8. PubMed ID: 19936577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct and indirect costs of management of long-term warfarin therapy in Canada.
    Schulman S; Anderson DR; Bungard TJ; Jaeger T; Kahn SR; Wells P; Wilson SJ
    J Thromb Haemost; 2010 Oct; 8(10):2192-200. PubMed ID: 20663051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Medial calcific sclerosis under long-term anticoagulation with vitamin K antagonists].
    Walther B
    Dtsch Med Wochenschr; 2013 May; 138(21):1102-6. PubMed ID: 23677504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vitamin K antagonists and platelet aggregation inhibitors in the prevention of thrombosis].
    Moriau M; Ferrant A
    Acta Clin Belg; 1977; 32(6):409-21. PubMed ID: 616752
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of diseases on response to vitamin K antagonists.
    Self TH; Owens RE; Sakaan SA; Wallace JL; Sands CW; Howard-Thompson A
    Curr Med Res Opin; 2016; 32(4):613-20. PubMed ID: 26695107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of anticoagulants during pregnancy].
    Lécuru F; Taurelle R; Desnos M; Ruscillo MM
    Presse Med; 1995 May; 24(19):901-4. PubMed ID: 7638132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.